Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and Vomiting
نویسنده
چکیده
Despite significant progress in the prevention of chemotherapy-induced nausea and vomiting (CINV) with the introduction of new antiemetic agents, 30-50% of patients receiving moderately or highly emetogenic chemotherapy (MEC or HEC) and guideline directed prophylactic antiemetics develop breakthrough CINV. International guidelines recommend the treatment of breakthrough CINV with an agent from a drug class that was not used in the prophylactic antiemetic regimen and recommend using the breakthrough medication continuously rather than using it on an as needed basis. There have been very few studies on the treatment of breakthrough CINV. A recent double-blind, randomized, phase III study suggested that olanzapine may be an effective agent for the treatment of breakthrough CINV. Refractory CINV occurs when patients develop CINV during subsequent cycles of chemotherapy when antiemetic prophylaxis has not been successful in controlling CINV in earlier cycles. Patients who develop refractory CINV should be considered for a change in their prophylactic antiemetic regimen. If significant anxiety exists, a benzodiazepine may be added to the prophylactic regimen. If a refractory patient is receiving HEC, olanzapine may be added to the prophylactic regimen. If the patient is receiving MEC, olanzapine or an NK-1 receptor antagonist may be added to the prophylactic regimen.
منابع مشابه
The Effect of Group Behavioral Activation Therapy on Chemotherapy - induced Nausea and Vomiting among Women with Breast Cancer
Background and Aim: Nausea and vomiting are one of the most common and worst side effects of chemotherapy in breast cancer patient and and despite the advances in medical science, Chemotherapy Induced Nausea and Vomiting is still a challenge to control.The aim of this study was to investigate the effect of group behavioral activation therapy on Chemotherapy Induced Nausea and Vomiting among wom...
متن کاملThe Affect of Ginger on the Severity of Nausea and Vomiting induced by Chemotherapy in Cancer' Patient Referred to Razi Hospital in Rasht 2007-2008
Introduction: nausea and vomiting caused by chemotherapy is the most important ‎complication and discomfort for cancer patients. Nausea and vomiting causes physiologic and ‎electrolyte disorders, Immunity system changes, Nutrition disorders and rupture of esophagus ‎and effect in the quality of life and continuing of patient's treatment. Ginger is one vegetable ‎and effective dr...
متن کاملPractical management of chemotherapy-induced nausea and vomiting.
Approximately 70% to 80% of all patients who receive chemotherapy experience nausea and vomiting, which can disrupt their lives in numerous ways. Chemotherapy-induced nausea and vomiting (CINV) has traditionally been classified according to three patterns: acute, delayed, and anticipatory. Additional classifications include refractory and breakthrough nausea and vomiting. The mechanisms by whic...
متن کاملChemotherapy Induced Nausea and Vomiting: Fear Makes the Wolf Bigger than He is
Chemotherapy induced nausea and vomiting (CINV) is one of the most feared and severe side effects of cancer treatment. It is broadly categorised as anticipatory (a conditioned reflex, due to past experience, generally triggered by same stimuli), acute (within 24 hours of chemotherapy administration), delayed (after 24 hours and lasting up to 7 days of chemotherapy), breakthrough (inspite of pri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
دوره 2015 شماره
صفحات -
تاریخ انتشار 2015